• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用随机森林模型预测抗LGI1脑炎的功能结局。

Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.

作者信息

Li Gongfei, Liu Xiao, Wang Minghui, Yu Tingting, Ren Jiechuan, Wang Qun

机构信息

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

出版信息

Acta Neurol Scand. 2022 Aug;146(2):137-143. doi: 10.1111/ane.13619. Epub 2022 Apr 4.

DOI:10.1111/ane.13619
PMID:35373330
Abstract

OBJECTIVES

To establish a model in order to predict the functional outcomes of patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis and identify significant predictive factors using a random forest algorithm.

METHODS

Seventy-nine patients with confirmed LGI1 antibodies were retrospectively reviewed between January 2015 and July 2020. Clinical information was obtained from medical records and functional outcomes were followed up in interviews with patients or their relatives. Neurological functional outcome was assessed using a modified Rankin Scale (mRS), the cutoff of which was 2. The prognostic model was established using the random forest algorithm, which was subsequently compared with logistic regression analysis, Naive Bayes and Support vector machine (SVM) metrics based on the area under the curve (AUC) and the accuracy.

RESULTS

A total of 79 patients were included in the final analysis. After a median follow-up of 24 months (range, 8-60 months), 20 patients (25%) experienced poor functional outcomes. A random forest model consisting of 16 variables used to predict the poor functional outcomes of anti-LGI1 encephalitis was successfully constructed with an accuracy of 83% and an F1 score of 60%. In addition, the random forest algorithm demonstrated a more precise predictive performance for poor functional outcomes in patients with anti-LGI1 encephalitis compared with three other models (AUC, 0.90 vs 0.80 vs 0.70 vs 0.64).

CONCLUSIONS

The random forest model can predict poor functional outcomes of patients with anti-LGI1 encephalitis. This model was more accurate and reliable than the logistic regression, Naive Bayes, and SVM algorithm.

摘要

目的

建立一个模型,以预测抗富含亮氨酸胶质瘤失活1(LGI1)脑炎患者的功能预后,并使用随机森林算法识别重要的预测因素。

方法

回顾性分析2015年1月至2020年7月期间79例确诊为LGI1抗体的患者。从病历中获取临床信息,并通过对患者或其亲属的访谈随访功能预后。使用改良Rankin量表(mRS)评估神经功能预后,其临界值为2。使用随机森林算法建立预后模型,随后基于曲线下面积(AUC)和准确性与逻辑回归分析、朴素贝叶斯和支持向量机(SVM)指标进行比较。

结果

最终分析共纳入79例患者。中位随访24个月(范围8 - 60个月)后,20例患者(25%)功能预后较差。成功构建了一个由16个变量组成的随机森林模型,用于预测抗LGI1脑炎患者的功能预后较差,准确率为83%,F1分数为60%。此外,与其他三种模型相比,随机森林算法在预测抗LGI1脑炎患者功能预后较差方面表现出更精确的预测性能(AUC分别为0.90、0.80、0.70和0.64)。

结论

随机森林模型可以预测抗LGI1脑炎患者的功能预后较差。该模型比逻辑回归、朴素贝叶斯和支持向量机算法更准确可靠。

相似文献

1
Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.使用随机森林模型预测抗LGI1脑炎的功能结局。
Acta Neurol Scand. 2022 Aug;146(2):137-143. doi: 10.1111/ane.13619. Epub 2022 Apr 4.
2
CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.脑脊液中的 CHI3L1 是抗亮氨酸丰富胶质瘤失活 1 脑炎的潜在生物标志物。
Front Immunol. 2023 Jan 5;13:1071219. doi: 10.3389/fimmu.2022.1071219. eCollection 2022.
3
Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.富含亮氨酸胶质瘤失活 1 型脑炎继发 Isaacs 综合征:抗富含亮氨酸胶质瘤失活 1 型抗体和接触蛋白相关蛋白样 2 交替出现。
Intern Med. 2023 Jun 1;62(11):1659-1663. doi: 10.2169/internalmedicine.9670-22. Epub 2022 Oct 12.
4
[Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis].[抗富含亮氨酸胶质瘤失活1型脑炎复发型和单相型患者的临床特征及预后]
Zhonghua Yi Xue Za Zhi. 2020 Jul 7;100(25):1947-1951. doi: 10.3760/cma.j.cn112137-20200330-01001.
5
Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.抗富含亮氨酸胶质瘤失活-1脑炎的临床特征、免疫治疗及预后
J Neuropsychiatry Clin Neurosci. 2022 Spring;34(2):141-148. doi: 10.1176/appi.neuropsych.20120303. Epub 2021 Nov 19.
6
Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission.抗 LGI1 脑炎缓解后免疫球蛋白反应性直立性低血压。
Intern Med. 2021 Sep 15;60(18):3021-3024. doi: 10.2169/internalmedicine.5359-20. Epub 2020 Oct 14.
7
Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.与电压门控钾通道复合物及富含亮氨酸胶质瘤失活1抗体相关的自身免疫性脑炎——一项全国性队列研究
Eur J Neurol. 2017 Aug;24(8):999-1005. doi: 10.1111/ene.13324. Epub 2017 May 25.
8
Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.中国队列中富含亮氨酸胶质瘤失活蛋白 1 和接触蛋白样 2 抗体相关自身免疫性脑炎的临床特征和结局。
J Clin Neurosci. 2022 Jul;101:137-143. doi: 10.1016/j.jocn.2022.05.007. Epub 2022 May 18.
9
LGI1 antibody encephalitis: acute treatment comparisons and outcome.LGI1 抗体脑炎:急性期治疗比较和结局。
J Neurol Neurosurg Psychiatry. 2022 Mar;93(3):309-315. doi: 10.1136/jnnp-2021-327302. Epub 2021 Nov 25.
10
Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.伴LGI1抗体的边缘性脑炎中癫痫的长期演变及预后因素
J Neurol. 2022 Sep;269(9):5061-5069. doi: 10.1007/s00415-022-11162-3. Epub 2022 May 20.

引用本文的文献

1
Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis.LGI-1-IgG自身免疫性脑炎中的认知及患者报告结局指标
Ann Clin Transl Neurol. 2025 Aug;12(8):1670-1679. doi: 10.1002/acn3.70105. Epub 2025 Jun 21.